Vaccines, Anti-sera & Immunoglobulin
Human Papillomavirus Bivalent (Types 16 & 18)
Papillomavirus vaccine is indicated in females from 9 years of age onwards for the prevention of persistent infection, premalignant cervical lesions and cervical cancer (squamous cell carcinoma and adenocarcinoma) caused by oncogenic human papillomaviruses (HPV).